Search for: "TEVA PHARMACEUTICAL USA, INC." Results 321 - 340 of 483
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
USPTO Grants Pfizer Reissue Patent for Celebrex®
1 Apr 2013, 8:29 am by Gene Quinn
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu
District Court Rules that Broad Measure of Damages Applies in False Claims Act Case, Greatly Increasing Defendants’ Exposure
21 Jul 2023, 4:47 pm by luiza
Teva Pharmaceuticals USA, Inc., No. 1:20-cv-11548 (D. [read post]
Whistleblower Insider - https://constantinecannon.com/practice/whistleblower/blog/
Obviousness: Is a Reasonable Expectation of Success Sufficient
19 Feb 2024, 12:55 pm by Dennis Crouch
Altoona Publix Theatres, Inc. v. [read post]
Patently-O - https://patentlyo.com
Pharma & Biotech Global Week in Review 24 March 2010 from IP Think Tank
24 Mar 2010, 4:45 am
Teva Pharamceuticals USA, Inc. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 23 June 2010 from IP Think Tank
23 Jun 2010, 10:28 pm
Teva Pharmaceuticals USA, Inc. et al. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Lawsuit Alleges False Marking Based on Orange Book “Advertising”
13 Apr 2011, 5:13 pm by FDABlog HPM
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2-10-cv-00836 (E.D. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Argument preview: Of patents, prior art and secret sales
27 Nov 2018, 9:30 am by Ronald Mann
Teva Pharmaceuticals USA Inc. presents the next one of those cases. [read post]
SCOTUSblog - http://www.scotusblog.com/
Leo Pharma v. Rea: Fleshing Out “Obvious to Try” Combinations
26 Aug 2013, 7:15 pm
USA, Inc., 367 F.3d 1381, 1385 (Fed. [read post]
Journal of the Patent and Trademark Office Society - http://jptos.org
THE 1% NEED ZYPREXA
16 Nov 2011, 10:00 am by Lucas A. Ferrara, Esq.
Reddy's Laboratories Ltd. and Teva Pharmaceuticals USA. [read post]
Real Estate Law Blog - http://www.nyrealestatelawblog.com/
Does a Subsequent Paragraph IV Filer Have a Legally Cognizable Interest in When a First-Filer’s 180-Day Exclusivity Period Begins for DJ Jurisdiction Purposes?
6 Oct 2010, 11:43 pm by FDABlog HPM
USA v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
The Federal Circuit Has Its Final Say the “On-Sale” Bar Under the AIA
2 Feb 2018, 1:31 pm by Gregory Sephton
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]
Kluwer Patent Blog - http://kluwerpatentblog.com
Guest Post by Prof. Holbrook: Whose Law Controls On Sale Prior Art in Foreign Countries?
4 Feb 2020, 5:00 am by Jason Rantanen
Teva Pharmaceuticals USA, Inc., the Supreme Court, in its first case addressing the AIA’s § 102, rejected this argument. [read post]
Patently-O - http://patentlyo.com/patent
Employment Releases that Don't Work
10 Jan 2007, 4:39 pm
Teva Pharmaceuticals USA 2006 WL 2529632 (E.D. [read post]
New York Employment Lawyer Blog - http://www.newyorkemploymentlawyerblog.com/
May a Patent Law Expert Opine as to the Materiality of Undisclosed Information?
23 Sep 2010, 12:02 pm by The Docket Navigator
Teva Pharmaceuticals USA Inc. et al., 1-08-cv-00464 (DED September 21, 2010 Memorandum) (Bartle, J.) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Clear Error Test Governs Review of Patent Rulings, Supreme Court Holds
20 Jan 2015, 8:27 am by Barry Barnett
In Teva Pharmaceuticals USA, Inc. v. [read post]
Blawgletter - http://blawgletter.typepad.com/bbarnett/
District Court Decision Sidesteps 30-Month Stay Tolling Issue; Denies Patent Infringement Litigation Stay
19 Apr 2010, 1:34 pm by FDABlog HPM
USA, Inc., 557 F.3d 1346 (Fed. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
FDA Denies Citizen Petition on Generic COMBIVIR 180-Day Exclusivity “First Applicant” Issue
1 Jun 2011, 5:51 pm by FDABlog HPM
Karst –       Last week, in a seven-page response, FDA denied an October 18, 2010 Citizen Petition submitted on behalf of Lupin Limited (“Lupin”) requesting that FDA determine that Teva Pharmaceuticals USA, Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Pharma & Biotech Global Week in Review 21 April 2010 from IP Think Tank
22 Apr 2010, 3:51 am
Teva Pharmaceutical Industries Ltd. et al. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 16 June 2010 from IP Think Tank
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Judge Andrews Issues Claim Construction Opinion Related to Anti-HIV Pharmaceuticals
21 Nov 2012, 11:32 am by Robert Vrana
Teva Pharmaceuticals USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/